Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S2k Guideline Diagnosis and Assessment of Lung Disease Caused by Occupational Silica Dust Exposure (Silicosis) - Clinical Practice Guidelines published by the German Respiratory Society (DGP).

Respiration; international review of thoracic diseases·2026
Same author

Factors influencing vaccination willingness in the context of the COVID-19 pandemic: data from the CoCo-Fakt study.

BMC public health·2026
Same author

Neighborhood allergenic trees and lung function from early adolescence up to early adulthood in Germany.

Environment international·2026
Same author

Toxic Metals in a Green Transition: Global Health Risks, Sources, and Policy Responses-Insights from the Munich Toxic Metals Symposium 2025.

Annals of global health·2026
Same author

SARS-CoV-2 Anti-Spike IgG Subclass Titres in a Population with Prior Exposure to Perfluorooctanoic Acid (PFOA).

Toxics·2026
Same author

Assessment of spirometric decline from silica dust: threshold values and calculation methods for cumulative exposure.

Journal of occupational medicine and toxicology (London, England)·2026

Related Experiment Video

Updated: Mar 10, 2026

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA
12:02

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA

Published on: May 2, 2018

13.1K

Medical diagnostics for indoor mold exposure.

Julia Hurraß1, Birger Heinzow2, Ute Aurbach3

  • 1Abteilung Infektions- und Umwelthygiene, Gesundheitsamt der Stadt Köln, Germany.

International Journal of Hygiene and Environmental Health
|December 18, 2016
PubMed
Summary
This summary is machine-generated.

This guideline helps physicians diagnose and treat indoor mold exposure. While mold can cause respiratory issues like asthma and allergies, infections are rare in healthy individuals.

Keywords:
DiagnosticsGuidelineHealthIndoorMoldRisk

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K

Related Experiment Videos

Last Updated: Mar 10, 2026

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA
12:02

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA

Published on: May 2, 2018

13.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K

Area of Science:

  • Environmental Medicine
  • Preventative Medicine
  • Allergology
  • Pulmonology

Background:

  • Indoor mold growth presents potential health risks, necessitating medical guidance for physicians.
  • Existing evidence links moisture/mold damage to allergic respiratory diseases, asthma, rhinitis, alveolitis, and respiratory infections.

Purpose of the Study:

  • To provide physicians with a guideline for the medical diagnosis of indoor mold exposure.
  • To aid in advising and treating patients affected by indoor mold.
  • To clarify the associations between mold exposure and various health effects.

Main Methods:

  • Development of a guideline by the German Society of Hygiene, Environmental Medicine and Preventative Medicine (GHUP) and other medical societies.
  • Inclusion of medical history, physical examination, and allergy diagnostics in suspected cases.
  • Referral to AWMF guidelines for invasive Aspergillus infections and acknowledgment of current limitations in mycotoxin diagnostics.

Main Results:

  • Sufficient evidence supports associations between mold and allergic respiratory diseases, asthma, rhinitis, alveolitis, and respiratory infections.
  • Limited or suspected evidence exists for associations with mucous membrane irritation and atopic eczema.
  • Infections from indoor molds are low risk for healthy individuals; mycotoxin detection lacks validated clinical tests.

Conclusions:

  • Indoor mold damages pose health risks, particularly for immunocompromised individuals and those with asthma or cystic fibrosis.
  • Physicians should consider mold exposure in diagnosis and treatment, focusing on established associations and risk groups.
  • Preventive medicine emphasizes the intolerance of mold damage in indoor environments.